This document summarizes ductal carcinoma in situ (DCIS), a non-invasive breast cancer confined to the breast ducts. It discusses the increasing incidence of DCIS due to mammogram screening, challenges in management, histologic features, mammographic appearance, prognostic factors, and treatment options including observation, breast-conserving surgery with or without radiation, and mastectomy. Controversy remains regarding optimal treatment, with the goal being eradication of cancer and prevention of invasive breast cancer.
http://cancer-treatment-madurai.com Breast cancer is a type of cancer that starts in the tissues of the breast. Dr.S.G.Balamurugan is one of the best cancer doctor in India, offers low cost breast cancer diagnosis, breast cancer treatments and breast cancer care at Guru Cancer Hospital, Madurai.
http://cancer-treatment-madurai.com Breast cancer is a type of cancer that starts in the tissues of the breast. Dr.S.G.Balamurugan is one of the best cancer doctor in India, offers low cost breast cancer diagnosis, breast cancer treatments and breast cancer care at Guru Cancer Hospital, Madurai.
Accelerated partial breast irradiation is an alternative to whole breast irradiation in carcinoma breast patients Post breast conserving surgery with equivalent outcome, less duration & less burden on the patient.
The combined use of radiation therapy and chemotherapy in cancer treatment is a logical and reasonable approach that has already proven beneficial for several malignancies.
Management of cacrinoma cervix: Techniques of radiotherapy (2D conventional, 3D Conformal radiotherapy (3DCRT) and IMRT with a review of various contouring guidelines.
Objective :
1 - compare between malignant and benign tumors.
2 - describe the stages and grading of tumor .
3 - describe dysplasia to carcinoma .
4 – list the different type of malignant adenoma in colon .
5 – what is metastasis and how it spread and the common sites of the metastasis adenocarcinoma in the colon .
6 - describe the CEA .
by asem shadid
Accelerated partial breast irradiation is an alternative to whole breast irradiation in carcinoma breast patients Post breast conserving surgery with equivalent outcome, less duration & less burden on the patient.
The combined use of radiation therapy and chemotherapy in cancer treatment is a logical and reasonable approach that has already proven beneficial for several malignancies.
Management of cacrinoma cervix: Techniques of radiotherapy (2D conventional, 3D Conformal radiotherapy (3DCRT) and IMRT with a review of various contouring guidelines.
Objective :
1 - compare between malignant and benign tumors.
2 - describe the stages and grading of tumor .
3 - describe dysplasia to carcinoma .
4 – list the different type of malignant adenoma in colon .
5 – what is metastasis and how it spread and the common sites of the metastasis adenocarcinoma in the colon .
6 - describe the CEA .
by asem shadid
Describe the normal anatomy of the breast in female ?
Describe the breast cancer and its different type ,stages and grading ?
List the tumor marker of breast cancer ?
Clinical significance of progesterone and estrogen in breast cancer ?
How the breast cancer spread in different sites ?
Define the paraneoplastic syndrome ?
Vaginal cancer is a rare type of cancer most common in women 60 and older.
Women are more likely to develop vaginal cancer if they have the human papillomavirus (HPV) or if your birth mother took diethylstilbestol (DES) when she was pregnant.
There are several types of vaginal cancer:
Squamous cell carcinoma
About 70 of every 100 cases of vaginal cancer are squamous cell carcinomas. These cancers begin in the squamous cells that make up the epithelial lining of the vagina. These cancers are more common in the upper area of the vagina near the cervix. Squamous cell cancers of the vagina often develop slowly. First, some of the normal cells of the vagina get pre-cancerous changes. Then some of the pre-cancer cells turn into cancer cells. This process can take many years.
The medical term most often used for this pre-cancerous condition is vaginal intraepithelial neoplasia (VAIN). "Intraepithelial" means that the abnormal cells are only found in the surface layer of the vaginal skin (epithelium). There are 3 types of VAIN: VAIN1, VAIN2, and VAIN3, with 3 indicating furthest progression toward a true cancer. VAIN is more common in women who have had their uterus removed (hysterectomy) and in those who were previously treated for cervical cancer or pre-cancer.
In the past, the term dysplasia was used instead of VAIN. This term is used much less now. When talking about dysplasia, there is also a range of increasing progress toward cancer - first, mild dysplasia; next, moderate dysplasia; and then severe dysplasia.
Adenocarcinoma
Cancer that begins in gland cells is called adenocarcinoma. About 15 of every 100 cases of vaginal cancer are adenocarcinomas. The usual type of vaginal adenocarcinoma typically develops in women older than 50. One certain type, called clear cell adenocarcinoma, occurs more often in young women who were exposed to diethylstilbestrol (DES) in utero (when they were in their mother’s womb). (See the section called "What are the risk factors for vaginal cancer?" for more information on DES and clear cell carcinoma.)
Melanoma
Melanomas develop from pigment-producing cells that give skin its color. These cancers usually are found on sun-exposed areas of the skin but can form on the vagina or other internal organs. About 9 of every 100 cases of vaginal cancer are melanomas. Melanoma tends to affect the lower or outer portion of the vagina. The tumors vary greatly in size, color, and growth pattern. More information about melanoma can be found in our document called Melanoma Skin Cancer.
Sarcoma
A sarcoma is a cancer that begins in the cells of bones, muscles, or connective tissue. Up to 4 of every 100 cases of vaginal cancer are sarcomas. These cancers form deep in the wall of the vagina, not on its surface. There are several types of vaginal sarcomas. Rhabdomyosarcoma is the most common type of vaginal sarcoma. It is most often found in children and is rare in adults. A sarcoma called leiomyosarcoma is seen more often in adults.
Breast Desmoid Tumor with Spectacular Evolution : A Case Report and Review of...semualkaira
Desmoid tumors or aggressive fibromatosis of the breast, are a rare entity, representing less than
0.2% of all primary breast tumors. The clinical presentation and evolution can mimic a malignant
carcinoma, with the notable difference that a desmoid tumor cannot generate distant metastases. The
aim of the treatment is to achieve local control of this tumor, which can be highly aggressive by
deeply infiltrating surrounding structures, and frequently reoccurs after resection. Both the tumor and
its treatment may cause significant morbidity, causing a real therapeutic challenge.
Breast Desmoid Tumor with Spectacular Evolution : A Case Report and Review of...semualkaira
Desmoid tumors or aggressive fibromatosis of the breast, are a rare entity, representing less than 0.2% of all primary breast tumors. The clinical presentation and evolution can mimic a malignant carcinoma, with the notable difference that a desmoid tumor cannot generate distant metastases.
Breast Desmoid Tumor with Spectacular Evolution : A Case Report and Review of...semualkaira
Desmoid tumors or aggressive fibromatosis of the breast, are a rare entity, representing less than 0.2% of all primary breast tumors. The clinical presentation and evolution can mimic a malignant carcinoma, with the notable difference that a desmoid tumor cannot generate distant metastases
Breast Cancer Management & Surgical ConsiderationsRiaz Rahman
Clinical overview and surgical considerations for management of Primary Breast Cancer and other subtypes. Covers screening recommendations, mammography (including BIRADS score interpretation), pathophysiology, staging, prognosis, surgical management, breast anatomy, non-surgical management, follow-up considerations. Given at Jackson Park Medical Center on 1/30/2014. Includes references.
Carcinoma breast and its management (1).pptxDr Sajad Nazir
This ppt is about carcinoma breast, its types,presentation, diagnosis, examination,management and recent trends in it.
Sentinel lymph node indications, axillary lymph node management.
Indications for chemotherapy and radiotherapy.
This is mainly for post graduates...
Kindly read anatomy of breast before proceeding for cancer breast and its management
It contains details about breast carcinoma-pathology,investigations and diagnosis,NACT,surgery and adjuvant therapy. Hope you will find it helpful.....
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
3. Its incidence is increasing due to over diagnosis by
screening mammogram
Considerable controversy regarding optimal
management
Ranges from observation to bcs to mastectomy with
and without adjuvant treatment
4. neoplastic process that is confined to the ductal
system of the breast and lacks histologic evidence of
invasion
These cells neither disrupt the basement membrane
nor involve the surrounding breast stroma.
lacks the ability to metastasize and is confined to the
breast
6. Before the use of screening mammography, DCIS typically
presented as a palpable mass or nipple discharge.
An invasive component commonly was found, and pure
DCIS rarely was encountered.
The widespread use of mammography now routinely
detects DCIS <1 cm in diameter
results in breast cancer-free survival rates that approach
100%
7. Ninety-five percent of new cases of DCIS present with
mammographic abnormalities
microcalcifications are most typical
asymmetric densities identified in 10%
dominant masses in 8%
abnormal galactograms (performed for evaluation of
nipple discharge) in 6%.
8. Linear and branching calcifications frequently are
associated with high-grade DCIS and necrosis, whereas
fine and granular calcifications are associated more
commonly with low-grade
Initial evaluation should include magnification views that
allow for complete characterization of mammographic
findings and determination of the need for biopsy
9.
10. The extent of the lesion as determined
mammographically may be used as a guide for excision
Ultrasonography, digital mammography, and magnetic
resonance imaging all have the potential to be helpful
in the management of DCIS
but have yet to be proven as an acceptable substitute
for mammography in screening
11. Traditionally, classification of DCIS has followed its
architectural or morphologic appearance
The five subtypes of DCIS are
Comedo
Solid
Cribriform
Micropapillary
papillary
12. it is common to encounter a mixture of subtypes within the
same specimen
Less common subtypes
Apocrine
Neuroendocrine
signet-cell cystic hypersecretory carcinoma
clinging DCIS
13. features that should be documented for each case of
DCIS
nuclear grade, presence of necrosis, polarization, and
architectural patterns
margin status, lesion size, extent of
microcalcifications, and correlation between specimen
x-ray and mammographic findings
14. Unicentric (one area only)
Multicentric (two distinct areas separated by more than 4
cm)
Continuous (extension along ductal system without gaps)
Discontinuous or multifocal (two or more areas separated
by <4 cm).
15. recognized association between the presence of DCIS
and the subsequent increased risk of developing an
invasive breast cancer
presence of shared identical genetic abnormalities
between DCIS and synchronous invasive breast cancer
demonstrates a clonal relationship of biologic
progression
16. The estrogen receptor is present in 70% of DCIS
Rate of expression is higher in low-grade lesions (90%)
than in high-grade lesions (25%).
This association with histologic grade is reversed for
the rate of overexpression of HER2/neu proto-
oncogene and the p53 tumor suppression gene.
17. An occult microinvasive tumor (<1mm) may be seen
with some cases of DCIS
Occult microinvasive tumors are most common in
patients with DCIS
Lesions that are >2.5 cm in diameter
Presenting with palpable masses or nipple discharge,
High-grade DCIS or comedonecrosis
18. A primary consideration in the natural history of DCIS is
the risk of progression to invasive carcinoma
The few published long-term follow-up studies of DCIS
after only biopsy document an overall incidence of
subsequent invasive carcinoma of more than 36%
Women with DCIS in one breast are at risk for a second
tumor (either invasive or in situ) in the contralateral breast
19. The goal of treatment with DCIS
eradication of the initial cancer
prevention of local recurrence, with particular
emphasis on the prevention of invasive breast cancer
20. The recommended workup and staging of DCIS includes:
history and physical examination
bilateral diagnostic mammography
MRI (optional)
pathology review
tumor ER determination
22. Mastectomy was the standard treatment of DCIS
through the first four decades
Mastectomy is a highly effective treatment for DCIS,
with a locoregional control rate of 96% to 100%
cancer-specific mortality rates of 4% or less
23. Many retrospective studies suggest that the rates of
local or regional recurrence are significantly lower
after mastectomy than after breast-conserving surgery
but there have been no significant differences in
overall survival
No prospective randomized trials comparing
mastectomy to breast-conserving surgery for DCIS
24.
25. Prospective randomized trials have shown that the
addition of whole breast irradiation to a margin-free
excision of pure DCIS
decreases the rate of in-breast disease recurrence, but
does not affect survival OR distant metastasis-free
survival.
26.
27. Whole breast irradiation after breast-conserving
surgery reduces the relative risk of a local failure by
approximately one half.
The current challenge is to identify women with DCIS
whose risk of an ipsilateral breast tumor recurrence
(primarily invasive) with breast-conserving surgery,
with or without radiation
28. Age
Women 40 years of age or younger with DCIS have been reported
to have ipsilateral breast tumor recurrence rates of approximately
50% in retrospective series n EORTC prospective randomized
trial.
Most of the prospective randomized trials suggest that
increasing age is associated with a decreased risk of ipsilateral
breast tumor recurrence
in patients treated with conservative surgery alone or
conservative surgery and radiation.
29. Methode of detection
detection of DCIS solely by mammography was
associated with a lower risk of ipsilateral breast tumor
recurrence
when compared with clinical detection with symptoms
such as a palpable mass or bloody nipple discharge
30. Size
Clinical assessment of tumor size includes measurements
of a palpable mass, the dimensions of the mammographic
abnormalities, including calcifications and/or a mass
In the EORTCand South Sweden prospective randomized
trials, increasing clinical size was associated with an
increased risk of ipsilateral breast tumor recurrence in
patients treated with conservative surgery alone
but not those treated with conservative surgery and
radiation
31. In the NSABP B-17 randomized trial the ipsilateral
breast tumor recurrence rate was correlated with the
extent of calcifications on the mammogram, both in
women treated with conservative surgery alone or
conservative surgery and radiation
In patients having calcifications, a postexcision
mammogram before radiation or observation is
essential to assure the removal of all malignant-
appearing calcifications
32. Multifocality
Multifocal DCIS has been associated with an increased
risk of ipsilateral breast tumor recurrence in different
prospective randomized trials
when compared with unifocal disease in patients
treated with conservative surgery alone or conservative
surgery and radiation
33. Resection margin status
Positive margins of resection have been associated with an
increased risk of ipsilateral breast tumor recurrence in the
NSABP B-17, EORTC, and the NSABP B-24 trials
Negative margins greater than or equal to 2 mm were
associated with a decreased risk of ipsilateral breast tumor
recurrence when compared with those less than 2 mm
Critical margin < 1mm and >10mm
34. High nuclear grade and the presence of necrosis have
been associated with an increased risk of ipsilateral
breast tumor recurrence in patients undergoing
conservative surgery
These factors have had less of an impact on ipsilateral
breast tumor recurrence rates in patients undergoing
conservative surgery and radiation
35. breast density is an increased risk of ipsilateral breast
tumor recurrence in women with DCIS.
36. a scoring system with four categories:
Age
Size
Margins
nuclear grade combined with necrosis
37. Van Nuys Prognostic Index
Parameter 1 Point 2 Points 3 Points
Size <15mm 16-40mm >40mm
Grade 1/II 1/II Necrosis III
Margin 10mm 1-9mm <1mm
Age >60 40-60 <40
4,5, 6 = Lumpectomy Alone
7, 8, 9 = Lumpectomy + Radiation
10, 11, 12 = Mastectomy
2003 Update PMID 14682107 -- "An argument against routine use of radiotherapy for ductal carcinoma
in situ." (Silverstein MJ, Oncology (Williston Park). 2003 Nov;17(11):1511-33; discussion 1533-4, 1539,
1542 passim.)
38. Total scores ranging from 4 to 12.
SCORE 4-6 7-9 10-12
BCS ONLY 4% 40% 87%
BCS +RT 4% 30% 38%
39. The investigators concluded that
patients with scores of 4 to 6 were candidates for wide
excision alone
scores of 7 to 9 for excision and radiation
scores of 10 to 12 for mastectomy.
40. The reproducibility of this system has been questioned
by a number of investigators in retrospective and
prospective studies.
Inaccuracies in calculating the score could result in
overtreatment or undertreatment
41. There is retrospective evidence suggesting that selected
patients have a low risk of in-breast recurrence with
excision alone without breast irradiation.
Retrospective study of 215 patients with DCIS treated with
lumpectomy without radiation therapy, endocrine therapy,
or chemotherapy, the
recurrence rate over 8 years was 0%, 21.5%, and 32.1% in
patients with low-, intermediate- or high-risk DCIS
42. A multi-institutional, nonrandomized, prospective study of
selected patients with low-risk DCIS treated without
radiation was studied
Although an acceptably low ipsilateral recurrence rate was
observed in the low-/intermediate-grade arm of the study
at 5 years
7-year ipsilateral recurrence rate in this group of patients
was considerably higher
43. An analysis of specimen margins and specimen
radiographs should be performed to ensure that all
mammographically detectable DCIS has been excised.
In addition, a post-excision mammogram should be
considered
45. NSABP B-24 trial
women with DCIS who were treated with breast-
conserving therapy were randomized to receive placebo or
tamoxifen.
13.6 years median follow-up, the women treated with
tamoxifen had a 3.4% absolute reduction in ipsilateral in-
breast tumor recurrence risk
No differences in overall survival (OS) were noted
46. lumpectomy plus radiation (category 1)
total mastectomy, with or without reconstruction (category
2A)
when persistent positive margin or multicentric tumors
lumpectomy alone followed by clinical observation
(category 2B).
47. history and physical examination every 6 to 12 months
for 5 years and then annually
as well as yearly diagnostic mammography.
48. characterized by multicentric breast involvement
Consists of loose, discohesive epithelial cells that are large
in size, variable in shape, and contain a normal cytoplasm
to nucleus ratio
The extent of involvement of the lobular lumen ranges
from simple filling to moderate-to-severe distention
with extension into the adjacent extralobular ducts
49. LCIS represents <15% of all noninvasive breast cancer
The majority of women are premenopausal at
diagnosis, with an average age of 45 years
There are no clinical or mammographic indicators that
are characteristic of LCIS
In excisional biopsy specimens, DCIS or invasive
carcinoma are frequently identified even when LCIS is
the sole histologic entity seen on core biopsy
50. multicentric distribution in up to 90% of mastectomy
specimens
bilateral involvement in 35% to 59%
LCIS cells are commonly estrogen-receptor positive
overexpression of c-erbB-2 and p53 are uncommon
The loss of e-cadherin is often observed
51. The presence of LCIS is considered a marker of
increased risk for the subsequent development of
invasive (usually ductal) carcinoma
greatest for high-grade or more extensive lesions
This risk appears to be nearly equal for both breasts
52. Depends on whether it is associated with another
malignancy (DCIS or invasive carcinoma)
Approximately 10% of early-stage breast cancers have
an associated component of LCIS
53. treatment approach is to manage the breast according
to the dominant malignant histology (DCIS or invasive
carcinoma) and disregard the presence of LCIS.
it is not necessary to pursue additional surgery to
obtain clear margins for LCIS
If LCIS is the sole histologic diagnosis, treatment
recommendations range from conservative to radical
54. Earlier days due to high frequency of contralateral
breast involvement it was justified to do contralateral
biopsy and even bilateral mastectomy
Observational studies after wide local excision alone
have led to a better understanding of the natural
history of this condition, and a more conservative
approach is now commonly practiced
55. In patients with LCIS as the sole histologic diagnosis,
the most widely accepted clinical practice is close observation
with regular physical examination and mammographic
surveillance
There is no role for radiotherapy in the management of LCIS.
Unilateral mastectomy both inadequate and illogical.
Bilateral prophylactic mastectomy is likely excessive
prophylactic approach in high-risk patients is to consider the use
of tamoxifen
56.
57. characterized by the presence of Paget's cells that are located
throughout the epidermis
Paget's disease is a rare entity representing <5% of all breast cancer
cases)
typically diagnosed in the fifth or sixth decade.
Synchronous bilateral and male Paget's disease have been reported
Paget's disease is associated with an underlying malignancy in more
than 95%
58. the disease originates from the underlying in situ or
invasive disease
There is histologic evidence of intraepithelial extension,
immunohistochemical studies, and evidence suggesting
that the epidermal keratinocytes release a motility factor,
heregulin
that results in the chemotaxis of Paget's cells that migrate
to the overlying nipple epidermis
59. Itching and burning of the nipple and areola.
There is a slow progression toward a crusting eczematoid
appearance that can extend to the periareolar skin.
If neglected, bleeding, pain, and ulceration can occur .
Alternatively, Paget's disease can be asymptomatic and
present as a pathologic finding after incidental surgical
removal of the nipple areolar complex
60. A palpable mass is detected in approximately 50% of patients at
diagnosis
more than 90% of cases this will be an invasive carcinoma.
if no palpable mass is detected, 66% to 86% will have an underlying
DCIS.
These associated malignancies are usually located centrally,
Mammographic findings are frequent in the presence of a palpable
mass
but normal mammograms are reported in as many as 50% of cases
61. clinical evaluation includes bilateral breast
examination
mammography, and biopsy to confirm the diagnosis of
Paget's disease and to fully evaluate the extent of the
associated malignancy
The prognosis does not dependent on the diagnosis of
Paget's disease, but rather on the associated
malignancy
62. Management of Paget's disease continues to evolve.
Mastectomy was employed in the past but this has been
increasingly supplanted by breast-conserving treatment
The infrequent occurrence of this disease entity
the range of disease presentations
variable extent of surgical resection has made the
evaluation of treatment options difficult
63. The combination of limited surgical resection and
postoperative radiotherapy appears to be the most
practical breast-conserving approach
Surgical resection should include the nipple areolar
complex with microscopically clear margins
surrounding both the Paget's disease and the
associated malignancy
Axillary-node involvement is rare (0% to 5%) and most likely is associated with an undetected focus of invasive carcinoma
DCIS 85% OF INSITU AND 20-25 % OF ALL BREAST MALIGNANCIES
Linear and branching calcifications frequently are associated with high-grade DCIS and necrosis, whereas fine and granular calcifications are associated more commonly with low-grade
The extent of the lesion as determined mammographically may be used as a guide for excision
Ultrasonography, digital mammography, and magnetic resonance imaging all have the potential to be helpful in the management of DCIS but have yet to be proven as an acceptable substitute for mammography in screening
In 1997 a consensus conference committee was convened to reach an agreement on the pathologic classification of DCIS and the identification of specific features that may convey prognostic significance
10 times risk
Both of these molecular markers are noted in <20% of low-grade lesions but are present in approximately two thirds of high-grade lesions.
the rate at which such tumors develop is similar to that among women with primary invasive breast cancer, approximately 0.5% to 1% per year.
HER2 status of DCIS does not alter the management strategy and routinely should not be determined
However, for each of the age groups, the addition of radiation decreased the risk of an ipsilateral breast tumor recurrence when compared with conservative surgery alone
All this followed by tamoxifen
As such, the lines of histologic delineation can become blurred between atypical ductal hyperplasia, LCIS, and, when ductal extension is seen, DCIS.
and the absence of this adhesion molecule may explain the growth pattern seen with LCIS
The fact that LCIS commonly involves both breasts makes treatment
Young age, diffuse high-grade lesion, and significant family history. tamoxifen reduce risk by 56%
Paget's cells are large and have hyperchromatic, round-to-oval nuclei with abundant amphophilic-to-clear cytoplasm. Mitoses are commonly seen, and the cells can be found in clusters or individually in the basal layers